Phosphorylated STAT3 (Tyr705) as a biomarker of response to pimozide treatment in triple-negative breast cancer.

Dees, Sundee

Phosphorylated STAT3 (Tyr705) as a biomarker of response to pimozide treatment in triple-negative breast cancer. [electronic resource] - Cancer biology & therapy 06 2020 - 506-521 p. digital

Publication Type: Journal Article

1555-8576

10.1080/15384047.2020.1726718 doi


Apoptosis
Biomarkers, Tumor--metabolism
Cell Movement
Cell Proliferation
Dopamine Antagonists--pharmacology
Female
Humans
Phosphorylation
Pimozide--pharmacology
STAT3 Transcription Factor--genetics
Triple Negative Breast Neoplasms--drug therapy
Tumor Cells, Cultured